Study links Ozempic, a diabetes drug, to doubled risk of rare, vision-threatening eye condition NAION.

A study confirms a link between Novo Nordisk's diabetes drug, Ozempic, and an increased risk of a rare eye condition called NAION, which can cause irreversible vision loss. Diabetes patients using Ozempic were more than twice as likely to develop NAION compared to those using other diabetes medications. Despite the low overall rate of NAION cases, doctors recommend informing patients about this potential risk.

3 months ago
16 Articles